Spector Partners is Lead Counsel in Mednax Securities Fraud Case

Spector Partners is Lead Counsel in Mednax Securities Fraud Case Spector Partners was recently appointed Lead Counsel in a securities fraud class action against MEDNAX, Inc., pending in the United States District Court for the Southern District of Florida. MEDNAX is a healthcare administration company that acquires and administers physician

Spector Partners is Lead Counsel in Mednax Securities Fraud Case Read More »

Spector Partners is Co-lead Counsel in Interior Molded Doors Antitrust Litigation

Spector Partners is Co-lead Counsel in Interior Molded Doors Antitrust Litigation Spector Partners was recently appointed Co-lead Counsel in an antitrust class action against the largest manufacturers of interior molded doors. The defendants: Masonite; JELD-WEN; and JELD-WEN Holding, control approximately 85% of the market. The case, pending in the United

Spector Partners is Co-lead Counsel in Interior Molded Doors Antitrust Litigation Read More »

Final Settlement in Blood Reagents Antitrust Litigation Approved by Court

Final Settlement in Blood Reagents Antitrust Litigation Approved by Court On October 24, 2018, in In re Blood Reagents Antitrust Litigation, a nation-wide price-fixing case against the major U.S. suppliers of blood reagents, in which Spector Partners was appointed Class Counsel for direct purchaser plaintiffs, e.g., American Red Cross, hospitals, blood

Final Settlement in Blood Reagents Antitrust Litigation Approved by Court Read More »

Court Preliminarily Approves Settlement in Liquidity Services Securities Action

Court Preliminarily Approves Settlement in Liquidity Services Securities Action On June 21, 2018, the United States District Court for the District of Columbia preliminarily approved a $17 million settlement in Howard v. Liquidity Services, Inc., No. 14-cv-1183 (D.D.C.).  SRK has been litigating the action as Co-Lead Counsel since 2014. Liquidity Services,

Court Preliminarily Approves Settlement in Liquidity Services Securities Action Read More »

Third Circuit Allows Spector Partners to Proceed with Effexor claims

Third Circuit Allows Spector Partners to Proceed with Effexor claims The Third Circuit Court of Appeals has just reversed dismissal of antitrust claims against Pfizer and Teva over the blood thinner Aggranox and its generic equivalents. Spector Partners is co-lead counsel in the case, alleging that Pfizer took anti-competitive actions

Third Circuit Allows Spector Partners to Proceed with Effexor claims Read More »

Scroll to Top